Josh Pacini (@joshpacini) 's Twitter Profile
Josh Pacini

@joshpacini

automating drug development + getting my dumb thoughts out here so I can focus on automating drug development

ID: 1722032215209709568

linkhttps://x.com/valinordiscover?s=21&t=H9a9VASlfPKmF5oB6YPB9Q calendar_today07-11-2023 23:24:43

714 Tweet

488 Takipçi

1,1K Takip Edilen

Josh Pacini (@joshpacini) 's Twitter Profile Photo

All innovations that have happened in AI for biology to date will be inconsequential compared to everything that happens after we have large, patient-derived datasets. In-human data is the bottleneck.

Kyle Harrison (@kwharrison13) 's Twitter Profile Photo

We need a TBPN fight night. Not an occasional one-off on AI margins. A consistent, at least weekly, intellectual octagon. Heated debate of the week? Play it out live on air.

Josh Pacini (@joshpacini) 's Twitter Profile Photo

I can’t think of a place outside the Bay Area where the prior generation of extremely successful people is actively looking to pay it forward to the rising generation. It’s one of many reasons why Silicon Valley hasn’t been replicated anywhere else.

Josh Pacini (@joshpacini) 's Twitter Profile Photo

Pretty insane how reliable of a heuristic responsiveness is for the quality of an investor. The most impressive investors I’ve chatted with move the quickest, almost without exception.

Josh Pacini (@joshpacini) 's Twitter Profile Photo

A common thread among the hottest firms (eg FF, Thrive, Elad) seems to be pursuing a barbell strategy (incubations AND very large growth checks). Less firms operate at those stages compared to traditional venture rounds, leading to less competition.

A common thread among the hottest firms (eg FF, Thrive, Elad) seems to be pursuing a barbell strategy (incubations AND very large growth checks).

Less firms operate at those stages compared to traditional venture rounds, leading to less competition.
Josh Pacini (@joshpacini) 's Twitter Profile Photo

Investing in nation-specific AI labs should be a pretty easy decision for large venture firms. Governments will subsidize their national winners, and you’ll be able to raise larger funds from domestic LPs and sovereign wealth funds.

Investing in nation-specific AI labs should be a pretty easy decision for large venture firms.

Governments will subsidize their national winners, and you’ll be able to raise larger funds from domestic LPs and sovereign wealth funds.
Josh Pacini (@joshpacini) 's Twitter Profile Photo

The shift from AI hype to biotech hype is already underway, even in the public markets. What better hedge to inflated AI companies than investing in biotechs trading below cash?

Josh Pacini (@joshpacini) 's Twitter Profile Photo

An underrated skill in good investors is making initial founder meetings feel authentic versus transactional. Totally changes the dynamic of the partnership

Josh Pacini (@joshpacini) 's Twitter Profile Photo

One of the largest benefits of the rise of crypto is the amount of new money now funding the deep tech wave (eg Brian Armstrong and Fred Ehrsam, James Fickel, the list is long) Massive capitalism whitepill